LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies. With a sustained investment in research and development, the LFB Group bases its strategy on its international deployment and the design of innovative therapies.
Looking for a particular LFB employee's phone or email?
LFB Questions
The LFB annual revenue was $742.8 million in 2026.
Jacques Brom is the CEO of LFB.
1,784 people are employed at LFB.
LFB is based in Courtaboeuf Cedex, Wallis and Futuna.
The NAICS codes for LFB are [54171, 5417, 541, 32, 541711, 325, 54].
The SIC codes for LFB are [283, 2834, 80, 28].
Top LFB Employees
-
Jacques Brom
Chief Executive Officer at LFB
Les Ulis, FR1 -
25+
-
31
-
Anne-Laurence Sabatini
Executive Vice President International Operations at LFB
Île-de-France, France13 -
Virginie Scanu
EVP HR, Group HR Director at LFB
Boulogne-Billancourt, FR1 -
Loret Vincent
EVP Operations at LFB
Lyon, FR2
Related Companies
